This educational activity is intended for rheumatologists, nurse practitioners and physician assistants who use biologics in their patients with rheumatoid arthritis (RA) and healthcare practitioners with an interest in and involved in the care of patients with RA.


After participating in this activity, participants should be better able to:

Classify RA patients failing primary TNF inhibitor therapy that may improve from a trial of a second TNF inhibitor
Distinguish alternative drug treatment strategies that may be beneficial for patients who have failed TNF inhibitor therapies